Breast cancer ► Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)







Last Updated: Sep 01, 2016

• 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
  Cardoso Fatima et al. The New England journal of medicine 2016 Aug 375(8) 717-29
• Breast cancer risk prediction using a clinical risk model and polygenic risk score.
  Shieh Yiwey et al. Breast cancer research and treatment 2016 Aug
• Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?
  Larouche Geneviève et al. Familial cancer 2016 Aug
• Study Of Breast Cancer Treatment Reveals Paradox Of Precision Medicine
  R Harris, NPR, August 24, 2016
• The Role of Genetic Testing in the Selection of Therapy for Breast Cancer: A Review.
  Niravath Polly et al. JAMA oncology 2016 Aug
• High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
  Rashid Muhammad Usman, et al. BMC cancer 2016 0 (1) 673
• Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
  Pinto Pedro, et al. Breast cancer research and treatment 2016 8
• Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.
  Guo Yan, et al. PLoS medicine 2016 8 (8) e1002105
• Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
  Hertz D L, et al. The pharmacogenomics journal 2016 8
• Psychosocial Adjustment and Perceived Risk Among Adolescent Girls From Families With BRCA1/2 or Breast Cancer History.
  Bradbury Angela R, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 8
• The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
  Liu Jingjing, et al. PloS one 2016 0 (8) e0161731
• Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, Study Says
  D Grady, New York Times, August 25, 2016
• ESR1 and PGR Polymorphisms Affect Estrogen and Progesterone Receptor Expression in Breast Tumors.
  Hertz Daniel L, et al. Physiological genomics 2016 8 physiolgenomics.00065.2016
• FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
  Kiiski Johanna I, et al. International journal of cancer 2016 8
• The Role of Genetic Testing in the Selection of Therapy for Breast Cancer- A Review
  P Niravath, JAMA Oncology, August 26, 2016

• CDC Information (9)
• CDC-Authored Pub (12)

• Human (144)
• Pathogen (1)

• Human (5290)
• Pathogen (0)

• Human (467)
• Pathogen (0)

• Guidelines (23)
• Tier Table (19)
• Synthesis (53)

• Huamn (122)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB